Indane-amines as PD-L1 antagonists
US11135210B2 · kind B2 · utility
8Cited by
7References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2020 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Jan 14, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2a, R2b, R2c, R3, R4, R5, R6a, R6b, m and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.